Tom Bache
About Tom Bache
Tom Bache is the Director of Worldwide Immunology Franchise Marketing and Commercialization at Bristol Myers Squibb, based in London. He has extensive experience in marketing and commercialization roles across the UK, Australia, and Scandinavia, with a background in genetics from Swansea University.
Company
Tom Bache is currently working at Bristol Myers Squibb, a global biopharmaceutical company. He holds the position of Director of Worldwide Immunology Franchise Marketing and Commercialization. His role involves overseeing marketing and commercial activities for the immunology franchise on a global scale.
Title
Tom Bache is the Director of Worldwide Immunology Franchise Marketing and Commercialization at Bristol Myers Squibb. This role places him in charge of global marketing strategies and commercialization efforts for the company’s immunology products.
Professional Experience at Eli Lilly and Company
Tom Bache has extensive experience working at Eli Lilly and Company. From 2017 to 2019, he served as the Marketing Director Specialty Care in Basingstoke. He also held the position of Customer Operations and Data Insights Manager for the UK and Scandinavia from 2015 to 2017. Additionally, he was the Business Unit Head for Specialty Products in 2014 and a Lean Six Sigma Black Belt in 2012-2013. Earlier roles included Senior Brand Manager/Leader for Zyprexa (2010-2012) and Brand Manager for Zyprexa (2009-2010).
Education and Expertise
Tom Bache studied Genetics at Swansea University, earning a Bachelor’s degree. His educational background has equipped him with a solid foundation in scientific principles. Bache also holds a Lean Six Sigma Black Belt certification, highlighting his skills in process improvement and operational efficiency.
Background in Secondary Care and Therapeutic Areas
Tom Bache has significant experience in secondary care business management. He worked as a Business Manager for Secondary Care at Organon Pharmaceuticals from 2005 to 2007. His background includes managing the commercialization of products like Implanon, a contraceptive implant, during his tenure at Schering Plough (2007-2008). His work in specialized therapeutics encompassed roles such as an Account Manager at Schering (2003-2005).